A new study identified two new functions of a neural regulatory protein, with possible clinical implications down the line.
A recent campus talk explored how clinical trials of HIV/AIDS drugs in developing countries in the 90s sparked a wealth of discussions about ethics in scientific investigation and barriers to healthcare access.
The safety of a new therapy for an aggressive brain tumor was demonstrated in a recent clinical trial, and the drug also cleared other important hurdles.
Northwestern Medicine scientists have identified a protein that helps reprogram HER2-positive breast cancer cells to survive in the brain, according to a recent study.
A new study measured changes in neural pathways after a stroke, finding that many patients’ nervous systems appear to shift activity to undamaged motor pathways from the brain and the brainstem.
A new blood test can identify early-stage liver cancer, allowing clinicians to start treatment early, according to a new study.
A new study has discovered previously unknown details about a mechanism that lets white blood cells travel from blood vessels into tissue, a process key to inflammation.
A molecule drastically reduced toxic proteins in human neuron cells with Huntington’s disease, representing a potential therapy for the deadly degenerative disease, according to a new study.
A new study has found that a particularly deadly form of pediatric brain tumor may have a weakness that could inspire future treatments.
Founders’ Day welcomes first-year medical students to campus, honors Feinberg’s founders and marks the official start of the academic year.